Compliance with out of state investigative requests, like warrants, just got a little trickier for California companies. Under existing law, California technology and communications companies are required to produce specified user data in response to an out of state warrant as if that warrant was issued by a California court. But now there is one caveat—companies do not have to do so when the warrant relates to an out of state abortion investigation. On September 27, 2022, California Governor Gavin Newsom signed a bill (AB-1242) that, in part, prohibits technology and communications companies headquartered or incorporated in California from providing user data to out-of-state law enforcement or government entities investigating abortions that would be lawful under California law. The new law also prohibits California companies from assisting the out-of-state entities in investigating or enforcing abortion violations. For California corporations, the law acts as a shield against warrants, court orders, subpoenas, or other legal processes from states attempting to enforce abortion laws that conflict with California law.

One Equity Partners (OEP) has announced it has completed the acquisition of Prime Time Healthcare.

Prime Time, based in Omaha, Neb., is a healthcare staffing services provider. Founded in 2012, the company states that it provides placement services for registered nurses, licensed practical nurses, certified nursing assistants and allied health clinicians to approximately 8,500…

At long last, the Financial Crimes Enforcement Network (“FinCEN”) issued a final rule establishing a beneficial ownership information reporting requirement for corporations and companies both large and small. In its announcement earlier today, FinCEN explained that the rule will require most companies and corporations registered to do business in the United States to report information about their beneficial owners to FinCEN.

Securities and Exchange Commission officials highlighted a commitment to restoring trust in the agency and aggressive enforcement during the recent SEC Speaks conference.

See our alert for analysis of their comments and stated enforcement priorities, which addressed crypto markets, aggressive use of remedies, creditworthy cooperation, the Wells process, aggressive litigation, disgorgement efforts, municipal securities, gatekeeper…

BlackRock Long Term Private Capital (LTPC) will acquire Paradigm Oral Health from shareholders including InTandem Capital Partners, according to a news release.

Paradigm, based in Lincoln, Neb., is an oral surgery and digital dentistry platform. Founded in 2018, the company states that it has partnered with more than 100 surgeons who provide care…

Waud Capital Partners (WCP) has announced it has completed the sale of GI Alliance (GIA).

GIA, based in Southlake, Texas, is a gastroenterology practice management company. Founded in 2018 and formed in partnership with WCP, GIA states that it provides services to nearly 700 independent gastroenterologists operating in Texas, Arkansas, Arizona, Colorado, Florida, Illinois,…

On September 15, 2022, GOL Linhas Aéreas Inteligentes S.A. (GOL), Brazil’s second largest domestic airline, resolved long-running parallel investigations by the U.S. Department of Justice (DOJ) and the Securities and Exchange Commission (SEC).

The São Paulo-based company, whose shares are traded on the New York Stock Exchange, consented to a cease-and-desist order with the SEC finding that it violated the anti-bribery, books and records, and internal accounting controls provisions of the Foreign Corrupt Practices Act (FCPA), and entered into a three-year deferred prosecution agreement (DPA) with DOJ to settle criminal charges for conspiracy to violate the anti-bribery and books and records provisions of the FCPA. The company will collectively pay $41.5 million in fines to the federal agencies and pay an additional $3.4 million in penalties and restitution to Brazilian authorities.

Latticework Capital Management has announced its acquisition of Catalina Research Institute (CRI).

CRI, based in Montclair, Calif., is a multidisciplinary clinical trials facility. Founded in 1997, the company specializes in the conduct of phase II through phase IV pharmaceutical drug studies.

Latticework, based in Dallas, makes control equity investments in the lower middle…

WindRose Health Investors has announced it has completed an investment in Third Wave Recovery Systems (TWRx).

TWRx, based in Las Vegas, is a pharmaceutical rebate manager. The company provides services to hospitals, long-term care (LTC) facilities and select specialty physician groups.

WindRose, based in New York, pursues control equity investments in healthcare companies.…